Full Text
Systematic Review Of Cost Effectiveness Of Gefitinib In The Treatment Of Non-Small Cell Lung Cancer In China

Abstract

Authors

C HU L Huang D Zhao L Xu

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×